In the Pacific region, limited pharmacy competition and distribution costs can affect medication pricing. Wegovy® (Semaglutide, Injectable pen) by Novo Nordisk has been FDA-approved since 2021 for Chronic weight management. Weight Method offers a separate option for Newark residents: licensed California providers evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program is priced at $199/month — same pricing regardless of location.
FDA-approved Wegovy prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Newark is already seeing results
Wegovy in Newark, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Wegovy to patients in Newark from $199/month with virtual consultations and direct-to-door shipping.
Wegovy® by Novo Nordisk is the FDA-approved Injectable pen Semaglutide product, taken Once weekly and approved in 2021 for Chronic weight management. Semaglutide works by mimicking incretin hormones that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. Weight Method is a separate telehealth program for Newark residents: licensed providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program starts at $199/month and includes the provider evaluation, the medication, ongoing care, and home delivery.
Newark's suburban communities are hearing more about GLP-1 treatments through word of mouth and national media. Wegovy® is the FDA-approved Injectable pen Semaglutide product manufactured by Novo Nordisk since 2021. Weight Method's separate program is straightforward: an online assessment, a virtual provider consultation, and compounded Semaglutide delivered to your Newark address at $199/month. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Wegovy from $199/month.
Get Started NowFree consultation. No commitment.